315 related articles for article (PubMed ID: 31394016)
1. Estimated impact of hepatitis C-positive lung donor utilization on US donor lung supply.
Mooney JJ; Purington N; Mohabir P; Dhillon GS
Am J Transplant; 2020 Jan; 20(1):289-297. PubMed ID: 31394016
[TBL] [Abstract][Full Text] [Related]
2. Changes in Utilization and Discard of Hepatitis C-Infected Donor Livers in the Recent Era.
Bowring MG; Kucirka LM; Massie AB; Luo X; Cameron A; Sulkowski M; Rakestraw K; Gurakar A; Kuo I; Segev DL; Durand CM
Am J Transplant; 2017 Feb; 17(2):519-527. PubMed ID: 27456927
[TBL] [Abstract][Full Text] [Related]
3. Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting antivirals.
La Hoz RM; Sandıkçı B; Ariyamuthu VK; Tanriover B
Am J Transplant; 2019 Nov; 19(11):3058-3070. PubMed ID: 31207073
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors.
Kwong AJ; Wall A; Melcher M; Wang U; Ahmed A; Subramanian A; Kwo PY
Am J Transplant; 2019 May; 19(5):1380-1387. PubMed ID: 30378723
[TBL] [Abstract][Full Text] [Related]
5. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
[TBL] [Abstract][Full Text] [Related]
6. Lung Donation and Transplant Recipient Outcomes at Independent vs Hospital-Based Donor Care Units.
Vail EA; Wang X; Schaubel DE; Reese PP; Cantu E; Martin ND; Abt PL; Olthoff KM; Kerlin MP; Christie JD; Neuman MD
JAMA Netw Open; 2024 Jun; 7(6):e2417107. PubMed ID: 38916893
[TBL] [Abstract][Full Text] [Related]
7. Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
Hepatology; 2019 Jun; 69(6):2381-2395. PubMed ID: 30706517
[TBL] [Abstract][Full Text] [Related]
8. Center-level trends in utilization of HCV-exposed donors for HCV-uninfected kidney and liver transplant recipients in the United States.
Bowring MG; Shaffer AA; Massie AB; Cameron A; Desai N; Sulkowski M; Garonzik-Wang J; Segev DL
Am J Transplant; 2019 Aug; 19(8):2329-2341. PubMed ID: 30861279
[TBL] [Abstract][Full Text] [Related]
9. Successful Lung Transplantation From Hepatitis C Positive Donor to Seronegative Recipient.
Khan B; Singer LG; Lilly LB; Chaparro C; Martinu T; Juvet S; Pipkin M; Waddell TK; Keshavjee S; Humar A; Cypel M
Am J Transplant; 2017 Apr; 17(4):1129-1131. PubMed ID: 27873483
[TBL] [Abstract][Full Text] [Related]
10. Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.
Watson J; Mulvihill MS; Cox ML; Rich L; Wolfe CR; Gray A; Hartwig MG
Clin Transplant; 2019 Mar; 33(3):e13476. PubMed ID: 30609162
[TBL] [Abstract][Full Text] [Related]
11. Lung Quality and Utilization in Controlled Donation After Circulatory Determination of Death Within the United States.
Mooney JJ; Hedlin H; Mohabir PK; Vazquez R; Nguyen J; Ha R; Chiu P; Patel K; Zamora MR; Weill D; Nicolls MR; Dhillon GS
Am J Transplant; 2016 Apr; 16(4):1207-15. PubMed ID: 26844673
[TBL] [Abstract][Full Text] [Related]
12. Using HCV-viremic organs for lung transplantation does not confer higher rejection rates compared to HCV-negative organs.
Afshar K; Schonhoft E; Kozuch J; Kafi A; Yung G; Pollema T; Golts E; Aslam S
Clin Transplant; 2024 Feb; 38(2):e15260. PubMed ID: 38369851
[TBL] [Abstract][Full Text] [Related]
13. Racial and Gender Disparities in Transplantation of Hepatitis C+ Hearts and Lungs.
Hannan HA; Goldberg DS
J Heart Lung Transplant; 2024 May; 43(5):780-786. PubMed ID: 38163451
[TBL] [Abstract][Full Text] [Related]
14. New insights into the rational use of HCV+ organs worldwide.
Morales JM; Sawinski D
Clin Transplant; 2019 Dec; 33(12):e13739. PubMed ID: 31648391
[TBL] [Abstract][Full Text] [Related]
15. Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.
Woolley AE; Singh SK; Goldberg HJ; Mallidi HR; Givertz MM; Mehra MR; Coppolino A; Kusztos AE; Johnson ME; Chen K; Haddad EA; Fanikos J; Harrington DP; Camp PC; Baden LR;
N Engl J Med; 2019 Apr; 380(17):1606-1617. PubMed ID: 30946553
[TBL] [Abstract][Full Text] [Related]
16. Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis C.
Shaikh OS; Rogal S; Malik A; Sharma V; Cacciarelli T
Exp Clin Transplant; 2020 Oct; 18(5):605-611. PubMed ID: 31324136
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: Single center experience.
Molnar MZ; Nair S; Cseprekal O; Yazawa M; Talwar M; Balaraman V; Podila PSB; Mas V; Maluf D; Helmick RA; Campos L; Nezakatgoo N; Eymard C; Horton P; Verma R; Jenkins AH; Handley CR; Snyder HS; Cummings C; Agbim UA; Maliakkal B; Satapathy SK; Eason JD
Am J Transplant; 2019 Nov; 19(11):3046-3057. PubMed ID: 31306549
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C viremic lung transplantation to aviremic recipients: Comprehensive outcomes and post-transplant viremia.
Khan S; Mazumder R; Wang X; Wang Y; Sims OT; Budev M; Carey W
Clin Transplant; 2024 May; 38(5):e15325. PubMed ID: 38716770
[TBL] [Abstract][Full Text] [Related]
19. The impact of hepatitis C viremic donor lung allograft characteristics on post-transplantation outcomes.
Woolley AE; Piechura LM; Goldberg HJ; Singh SK; Coppolino A; Baden LR; Mallidi HR
Ann Cardiothorac Surg; 2020 Jan; 9(1):42-48. PubMed ID: 32175238
[TBL] [Abstract][Full Text] [Related]
20. Can we mitigate the effects of simultaneous liver-kidney transplantation through increased utilization of HCV-positive donors?
Sibulesky L; Perkins JD; Landis CS; Johnson CK
Am J Transplant; 2018 Oct; 18(10):2604-2605. PubMed ID: 30102461
[No Abstract] [Full Text] [Related]
[Next] [New Search]
